Breadcrumb
- Home
- Market & Technical Intelligence
- Advanced Search
- Report Information
NORTH AMERICA WESTERN BLOTTING MARKET 2019-2027
Publisher: Trition
Published: 2019/08/01
Page: 66
Format: PDF
MARKET OUTLOOK
Triton Market Research has concluded that the North America western blotting market would grow at 3.80% of CAGR throughout the forecast duration 2019-2027.
The countries of the United States and Canada together form the market for western blotting in the North American region.
Surging healthcare expenditure has helped to increase the consumption of bio-based reagents in the Canadian market. Moreover, increasing investment in research-based funding by government organizations in Canada has also helped to increase the laboratory and clinical research involving the use of reagents. In the year 2016, the ministry of health in Canada provided a funding of about $13.2 million for health projects. Increasing healthcare expenditure has become the key factor for the growth of the market, owing to the rising number of chronic diseases. In 2015, lung cancer was one of the most common cancer types in Canada, with a total number of cases counting to about 26,600. As per ‘Canadian Cancer Statistics 2015’, about 2 in 5 Canadians were anticipated to develop cancer throughout their lifetimes. In 2015, health expenditure in Canada was estimated to be about $219.1 million, with more than 60% directed to drugs, physicians and hospitals. This has uplifted the demand for biotechnology reagents in the country.
COMPETITIVE OUTLOOK
Few of the prime players in the western blotting market are Bio-Techne Corporation, Cell Signaling Technology, Inc., GE Healthcare, Li-Cor, Inc., Advansta, Azure Biosystems, Inc. and PerkinElemer, Inc.
Triton Market Research has concluded that the North America western blotting market would grow at 3.80% of CAGR throughout the forecast duration 2019-2027.
The countries of the United States and Canada together form the market for western blotting in the North American region.
Surging healthcare expenditure has helped to increase the consumption of bio-based reagents in the Canadian market. Moreover, increasing investment in research-based funding by government organizations in Canada has also helped to increase the laboratory and clinical research involving the use of reagents. In the year 2016, the ministry of health in Canada provided a funding of about $13.2 million for health projects. Increasing healthcare expenditure has become the key factor for the growth of the market, owing to the rising number of chronic diseases. In 2015, lung cancer was one of the most common cancer types in Canada, with a total number of cases counting to about 26,600. As per ‘Canadian Cancer Statistics 2015’, about 2 in 5 Canadians were anticipated to develop cancer throughout their lifetimes. In 2015, health expenditure in Canada was estimated to be about $219.1 million, with more than 60% directed to drugs, physicians and hospitals. This has uplifted the demand for biotechnology reagents in the country.
COMPETITIVE OUTLOOK
Few of the prime players in the western blotting market are Bio-Techne Corporation, Cell Signaling Technology, Inc., GE Healthcare, Li-Cor, Inc., Advansta, Azure Biosystems, Inc. and PerkinElemer, Inc.
TABLE OF CONTENT
1. NORTH AMERICA WESTERN BLOTTING MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. GROWING NUMBER OF APPLICATIONS FOR WESTERN BLOTTING
2.2.2. GROWING ACCEPTANCE OF DIGITAL WESTERN BLOTTING
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF SUPPLIERS
2.3.4. BARGAINING POWER OF BUYERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. GROWING OCCURRENCE OF HIV AND LYME DISEASE
2.6.2. HIGH DEMAND FOR PROTEOMICS
2.6.3. RISE IN APPLICATIONS FOR WESTERN BLOTTING
2.7. MARKET RESTRAINTS
2.7.1. ADVANCEMENTS IN SUBSTITUTE TECHNOLOGIES
2.8. MARKET OPPORTUNITIES
2.8.1. INDUSTRIALIZATION OF WESTERN BLOT INSTRUMENTS
2.9. MARKET CHALLENGES
2.9.1. INFLATED COST OF ANTIBODIES
2.9.2. GROWING RESEARCH INITIATIVES AND R&D EXPENDITURE BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
3. WESTERN BLOTTING MARKET OUTLOOK - BY PRODUCT
3.1. CONSUMABLES
3.1.1. REAGENTS AND BUFFERS
3.1.2. KITS
3.1.3. OTHER CONSUMABLES
3.2. INSTRUMENTS
3.2.1. GEL ELECTROPHORESIS INSTRUMENTS
3.2.2. BLOTTING SYSTEMS
3.2.2.1. DRY BLOTTING SYSTEMS
3.2.2.2. SEMI-DRY BLOTTING SYSTEMS
3.2.2.3. WET BLOTTING SYSTEMS
3.2.3. IMAGERS
3.2.3.1. CHEMILUMINESCENT IMAGERS
3.2.3.2. FLUORESCENT IMAGERS
3.2.3.3. OTHER IMAGERS
4. WESTERN BLOTTING MARKET OUTLOOK - BY APPLICATION
4.1. BIOMEDICAL & BIOCHEMICAL RESEARCH
4.2. DISEASE DIAGNOSTICS
4.3. AGRICULTURE
4.4. OTHER APPLICATIONS
5. WESTERN BLOTTING MARKET OUTLOOK - BY END-USER
5.1. RESEARCH INSTITUTES
5.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.3. DIAGNOSTIC CENTERS
5.4. OTHER END-USERS
6. WESTERN BLOTTING MARKET - REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
7. COMPETITIVE LANDSCAPE
7.1. F. HOFFMAN LA-ROCHE LTD.
7.2. MERCK KGAA
7.3. THERMO FISHER SCIENTIFIC, INC.
7.4. BIO-RAD TECHNOLOGIES, INC.
7.5. BIO-TECHNE CORPORATION
7.6. CELL SIGNALING TECHNOLOGY, INC.
7.7. GE HEALTHCARE
7.8. LI-COR, INC.
7.9. ADVANSTA
7.10. AZURE BIOSYSTEMS, INC.
7.11. PERKINELEMER, INC.
7.12. ROCHE DIAGNOSTICS INTERNATIONAL, INC.
7.13. ROCHE DIAGNOSTICS
7.14. LUMIGEN, INC.
7.15. ROCKLAND IMMUNOCHEMICALS, INC.
8. METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY
LIST OF TABLES
TABLE 1. NORTH AMERICA WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 2. MARKET ATTRACTIVENESS INDEX
TABLE 3. VENDOR SCORECARD
TABLE 4. NORTH AMERICA WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 5. NORTH AMERICA WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)
TABLE 6. NORTH AMERICA WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2027 (IN $ MILLION)
TABLE 7. NORTH AMERICA WESTERN BLOTTING MARKET, BY END-USER, 2019-2027 (IN $ MILLION)
LIST OF FIGURES
FIGURE 1. PORTER’S FIVE FORCE ANALYSIS
FIGURE 2. NORTH AMERICA WESTERN BLOTTING MARKET, BY CONSUMABLES, 2019-2027 (IN $ MILLION)
FIGURE 3. NORTH AMERICA WESTERN BLOTTING MARKET, BY REAGENTS AND BUFFERS, 2019-2027 (IN $ MILLION)
FIGURE 4. NORTH AMERICA WESTERN BLOTTING MARKET, BY KITS, 2019-2027 (IN $ MILLION)
FIGURE 5. NORTH AMERICA WESTERN BLOTTING MARKET, BY OTHER CONSUMABLES, 2019-2027 (IN $ MILLION)
FIGURE 6. NORTH AMERICA WESTERN BLOTTING MARKET, BY INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 7. NORTH AMERICA WESTERN BLOTTING MARKET, BY GEL ELECTROPHORESIS INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 8. NORTH AMERICA WESTERN BLOTTING MARKET, BY BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 9. NORTH AMERICA WESTERN BLOTTING MARKET, BY DRY BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 10. NORTH AMERICA WESTERN BLOTTING MARKET, BY SEMI-DRY BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 11. NORTH AMERICA WESTERN BLOTTING MARKET, BY WET BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 12. NORTH AMERICA WESTERN BLOTTING MARKET, BY IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 13. NORTH AMERICA WESTERN BLOTTING MARKET, BY CHEMILUMINESCENT IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 14. NORTH AMERICA WESTERN BLOTTING MARKET, BY FLUORESCENT IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 15. NORTH AMERICA WESTERN BLOTTING MARKET, BY OTHER IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 16. NORTH AMERICA WESTERN BLOTTING MARKET, BY BIOMEDICAL & BIOCHEMICAL RESEARCH, 2019-2027 (IN $ MILLION)
FIGURE 17. NORTH AMERICA WESTERN BLOTTING MARKET, BY DISEASE DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 18. NORTH AMERICA WESTERN BLOTTING MARKET, BY AGRICULTURE, 2019-2027 (IN $ MILLION)
FIGURE 19. NORTH AMERICA WESTERN BLOTTING MARKET, BY OTHER APPLICATIONS, 2019-2027 (IN $ MILLION)
FIGURE 20. NORTH AMERICA WESTERN BLOTTING MARKET, BY RESEARCH INSTITUTES, 2019-2027 (IN $ MILLION)
FIGURE 21. NORTH AMERICA WESTERN BLOTTING MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 (IN $ MILLION)
FIGURE 22. NORTH AMERICA WESTERN BLOTTING MARKET, BY DIAGNOSTIC CENTERS, 2019-2027 (IN $ MILLION)
FIGURE 23. NORTH AMERICA WESTERN BLOTTING MARKET, BY OTHER END-USERS, 2019-2027 (IN $ MILLION)
FIGURE 24. NORTH AMERICA WESTERN BLOTTING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 25. UNITED STATES WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 26. CANADA WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
1. NORTH AMERICA WESTERN BLOTTING MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. GROWING NUMBER OF APPLICATIONS FOR WESTERN BLOTTING
2.2.2. GROWING ACCEPTANCE OF DIGITAL WESTERN BLOTTING
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF SUPPLIERS
2.3.4. BARGAINING POWER OF BUYERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. GROWING OCCURRENCE OF HIV AND LYME DISEASE
2.6.2. HIGH DEMAND FOR PROTEOMICS
2.6.3. RISE IN APPLICATIONS FOR WESTERN BLOTTING
2.7. MARKET RESTRAINTS
2.7.1. ADVANCEMENTS IN SUBSTITUTE TECHNOLOGIES
2.8. MARKET OPPORTUNITIES
2.8.1. INDUSTRIALIZATION OF WESTERN BLOT INSTRUMENTS
2.9. MARKET CHALLENGES
2.9.1. INFLATED COST OF ANTIBODIES
2.9.2. GROWING RESEARCH INITIATIVES AND R&D EXPENDITURE BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
3. WESTERN BLOTTING MARKET OUTLOOK - BY PRODUCT
3.1. CONSUMABLES
3.1.1. REAGENTS AND BUFFERS
3.1.2. KITS
3.1.3. OTHER CONSUMABLES
3.2. INSTRUMENTS
3.2.1. GEL ELECTROPHORESIS INSTRUMENTS
3.2.2. BLOTTING SYSTEMS
3.2.2.1. DRY BLOTTING SYSTEMS
3.2.2.2. SEMI-DRY BLOTTING SYSTEMS
3.2.2.3. WET BLOTTING SYSTEMS
3.2.3. IMAGERS
3.2.3.1. CHEMILUMINESCENT IMAGERS
3.2.3.2. FLUORESCENT IMAGERS
3.2.3.3. OTHER IMAGERS
4. WESTERN BLOTTING MARKET OUTLOOK - BY APPLICATION
4.1. BIOMEDICAL & BIOCHEMICAL RESEARCH
4.2. DISEASE DIAGNOSTICS
4.3. AGRICULTURE
4.4. OTHER APPLICATIONS
5. WESTERN BLOTTING MARKET OUTLOOK - BY END-USER
5.1. RESEARCH INSTITUTES
5.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.3. DIAGNOSTIC CENTERS
5.4. OTHER END-USERS
6. WESTERN BLOTTING MARKET - REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
7. COMPETITIVE LANDSCAPE
7.1. F. HOFFMAN LA-ROCHE LTD.
7.2. MERCK KGAA
7.3. THERMO FISHER SCIENTIFIC, INC.
7.4. BIO-RAD TECHNOLOGIES, INC.
7.5. BIO-TECHNE CORPORATION
7.6. CELL SIGNALING TECHNOLOGY, INC.
7.7. GE HEALTHCARE
7.8. LI-COR, INC.
7.9. ADVANSTA
7.10. AZURE BIOSYSTEMS, INC.
7.11. PERKINELEMER, INC.
7.12. ROCHE DIAGNOSTICS INTERNATIONAL, INC.
7.13. ROCHE DIAGNOSTICS
7.14. LUMIGEN, INC.
7.15. ROCKLAND IMMUNOCHEMICALS, INC.
8. METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY
LIST OF TABLES
TABLE 1. NORTH AMERICA WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 2. MARKET ATTRACTIVENESS INDEX
TABLE 3. VENDOR SCORECARD
TABLE 4. NORTH AMERICA WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 5. NORTH AMERICA WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)
TABLE 6. NORTH AMERICA WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2027 (IN $ MILLION)
TABLE 7. NORTH AMERICA WESTERN BLOTTING MARKET, BY END-USER, 2019-2027 (IN $ MILLION)
LIST OF FIGURES
FIGURE 1. PORTER’S FIVE FORCE ANALYSIS
FIGURE 2. NORTH AMERICA WESTERN BLOTTING MARKET, BY CONSUMABLES, 2019-2027 (IN $ MILLION)
FIGURE 3. NORTH AMERICA WESTERN BLOTTING MARKET, BY REAGENTS AND BUFFERS, 2019-2027 (IN $ MILLION)
FIGURE 4. NORTH AMERICA WESTERN BLOTTING MARKET, BY KITS, 2019-2027 (IN $ MILLION)
FIGURE 5. NORTH AMERICA WESTERN BLOTTING MARKET, BY OTHER CONSUMABLES, 2019-2027 (IN $ MILLION)
FIGURE 6. NORTH AMERICA WESTERN BLOTTING MARKET, BY INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 7. NORTH AMERICA WESTERN BLOTTING MARKET, BY GEL ELECTROPHORESIS INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 8. NORTH AMERICA WESTERN BLOTTING MARKET, BY BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 9. NORTH AMERICA WESTERN BLOTTING MARKET, BY DRY BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 10. NORTH AMERICA WESTERN BLOTTING MARKET, BY SEMI-DRY BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 11. NORTH AMERICA WESTERN BLOTTING MARKET, BY WET BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 12. NORTH AMERICA WESTERN BLOTTING MARKET, BY IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 13. NORTH AMERICA WESTERN BLOTTING MARKET, BY CHEMILUMINESCENT IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 14. NORTH AMERICA WESTERN BLOTTING MARKET, BY FLUORESCENT IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 15. NORTH AMERICA WESTERN BLOTTING MARKET, BY OTHER IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 16. NORTH AMERICA WESTERN BLOTTING MARKET, BY BIOMEDICAL & BIOCHEMICAL RESEARCH, 2019-2027 (IN $ MILLION)
FIGURE 17. NORTH AMERICA WESTERN BLOTTING MARKET, BY DISEASE DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 18. NORTH AMERICA WESTERN BLOTTING MARKET, BY AGRICULTURE, 2019-2027 (IN $ MILLION)
FIGURE 19. NORTH AMERICA WESTERN BLOTTING MARKET, BY OTHER APPLICATIONS, 2019-2027 (IN $ MILLION)
FIGURE 20. NORTH AMERICA WESTERN BLOTTING MARKET, BY RESEARCH INSTITUTES, 2019-2027 (IN $ MILLION)
FIGURE 21. NORTH AMERICA WESTERN BLOTTING MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 (IN $ MILLION)
FIGURE 22. NORTH AMERICA WESTERN BLOTTING MARKET, BY DIAGNOSTIC CENTERS, 2019-2027 (IN $ MILLION)
FIGURE 23. NORTH AMERICA WESTERN BLOTTING MARKET, BY OTHER END-USERS, 2019-2027 (IN $ MILLION)
FIGURE 24. NORTH AMERICA WESTERN BLOTTING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 25. UNITED STATES WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 26. CANADA WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)